Mirion Technologies Inc's Corporate Customers have recorded an advance in their cost of revenue by 5.52 % in the 2 quarter 2026 year on year, sequentially costs of revenue were trimmed by -28.78 %. During the corresponding time, Mirion Technologies Inc recorded a revenue increase by 19.91 % year on year, sequentially revenue grew by 3.77 %. While revenue at the Mirion Technologies Inc 's corporate clients recorded rose by 7.7 % year on year, sequentially revenue fell by -25.09 %.
Mirion Technologies Inc's Customers have recorded an advance in their cost of revenue by 5.52 % in the 2 quarter 2026 year on year, sequentially costs of revenue were trimmed by -28.78 %, for the same period Mirion Technologies Inc recorded revenue increase by 19.91 % year on year, sequentially revenue grew by 3.77 %.
Mirion Technologies Inc's Comment on Sales, Marketing and Customers
The company's principal customers include power and utility companies, reactor design firms, nuclear power plants, hospitals, clinics, urgent care facilities, dental offices, veterinary offices, radiation treatment facilities, original equipment manufacturers for radiation therapy, laboratories, military organizations, government agencies, and industrial companies. No single customer accounted for more than 5% of consolidated revenue in the fiscal years ended December 31, 2025, 2024, and 2023. The top five customers represented approximately 13%, 11%, and 12% of consolidated revenue, respectively, while the top ten customers accounted for approximately 19%, 17%, and 19% during those years.
Innovative Nuclear Technology Paves the Way: Mirion Technologies Secures Pivotal Role in TerraPower s Natrium Reactor Project In a significant development for the future of clean energy, Mirion Technologies (NYSE: MIR) has been awarded crucial contracts for the supply of Radiation Monitoring and Nuclear Instrumentation Systems to support TerraPower s Natrium Reactor Demonstration Project in Wyoming. This ambitious initiative, hailed as the first commercial advanced nuclear power plant in the United States, promises to reshape the landscape of nuclear energy. The project is a product of a strategic public-private partnership, integrating the pioneering expertise of TerraPower, a front-runner in nuclear innova...
In the ever-evolving landscape of technological advancements, Mirion Technologies Inc. stands as a beacon of innovation within the radiation safety sector, making significant strides in both nuclear power and cancer care solutions. Today, December 3, 2024, marks a pivotal moment for the company as it hosts an Investor Day at the prestigious New York Stock Exchange. This event, eagerly anticipated by investors and industry analysts alike, promises a comprehensive overview of Mirion’s financial targets and long-term strategic direction.Headquartered in Atlanta, Mirion has established itself as a key player in the radiation safety domain, providing sophisticated solutions that enhance safety measures and supp...
Mirion Technologies Inc. (NYSE: MIR) is in the spotlight as the company prepares to participate in the upcoming Goldman Sachs Industrials and Materials Conference in New York. CEO Thomas Logan and CFO Brian Schopfer are set to present on December 5, 2024, beginning at 10:40 AM ET. Investors and analysts alike are anticipating insights into the company s strategic direction and financial performance, which will be featured in a live webcast available on Mirion s Investor Relations Page.As preparations for the conference unfold, Mirion has been demonstrating robust financial resilience in the market. For the current month, Mirion s stock has outperformed the broader market, exhibiting a commendable performance...
In a significant development towards combating climate change and supporting clean energy, Mirion Technologies, a leading provider of advanced radiation safety solutions, has signed an agreement with nuclear innovation company TerraPower. The collaboration aims to design and fabricate crucial components for the Molten Chloride Reactor Experiment (MCRE), the world s first critical fast-spectrum salt reactor. This article examines the impact of this partnership and analyzes key financial and industry trends affecting Mirion Technologies. 1. Mirion Technologies and TerraPower Join Forces for the Molten Chloride Reactor Experiment: Mirion Technologies proudly announces a collaboration with Terr...
Mirion Technologies Inc’s Comment on Sales, Marketing and Customers
The company's principal customers include power and utility companies, reactor design firms, nuclear power plants, hospitals, clinics, urgent care facilities, dental offices, veterinary offices, radiation treatment facilities, original equipment manufacturers for radiation therapy, laboratories, military organizations, government agencies, and industrial companies. No single customer accounted for more than 5% of consolidated revenue in the fiscal years ended December 31, 2025, 2024, and 2023. The top five customers represented approximately 13%, 11%, and 12% of consolidated revenue, respectively, while the top ten customers accounted for approximately 19%, 17%, and 19% during those years.
Sources:
Mirion Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Mirion Technologies Inc’s corporate clients.
For your research, we’ve provided 9 tables on Mirion Technologies Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
150.41 %
19.86 %